Resmed vs Stryker: revenue, profit, margins and growth compared
Resmed brought in $5.7B of revenue in fiscal 2026, Stryker $25.1B in fiscal 2025. Revenue changed by +9.9% at Resmed and +11.2% at Stryker on the year before, so Stryker grew faster. Resmed kept 26.9% of its revenue as net profit, Stryker 12.9%. Free cash flow was $1.6B at Resmed and $4.3B at Stryker.
Fiscal years as each company reports them; the two may end in different months.
Questions about Resmed and Stryker
Which is bigger by revenue, Resmed or Stryker?
Stryker is bigger by revenue: $25.1B in fiscal 2025, against $5.7B for Resmed in fiscal 2026.
Which keeps more of its revenue as profit, Resmed or Stryker?
Resmed had a net margin of 26.9% in fiscal 2026; Stryker had 12.9% in fiscal 2025.
Which grew revenue faster, Resmed or Stryker?
In their latest fiscal years revenue changed by +9.9% at Resmed and +11.2% at Stryker.
Where do these numbers come from?
From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.